Considering the clinical importance of elevated CD98hc expression in several human cancers, this Anticalin, charged with appropriate radionuclides or toxic payloads, constitutes a promising new tool for preclinical and, potentially, clinical applications in oncology. This evidence concerns the gene SLC3A2 and cancer.